Abstract
Binding of drugs to plasma protein has been known for many years to be significant in both drug effects and pharmacokinetics (Goldstein, 1949; Gillette, 1973; Curry, 1980; Meyer and Guttman, 1968; Vallner, 1974). However, in spite of rigorous study, binding remains contentious and poorly understood. This review is concerned with binding phenomena concernmg psychotropic drugs, methods of study, and pharmacological significance. Tissue binding is also considered. Special attention is given to the most popular assessment technique—equilibrium dialysis. This technique has recently undergone rigorous reevaluation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abel J. G., Sellers E. M, Naranlo C. A., Shaw J., Kader L., and Romach M. K. (1979) Inter-and intrasublect variation m diazepam free fraction. Clin. Pharmacol. Ther 26 247–255.
Ahmad A. B., Bennett P. N, and Rowland M. (1983) Models of hepatic clearance. Discrimination between the “well stirred” and paralleltube models J Pharm, Pharmacol 35 219–224.
Albert A. (1981) Selective Toxzclty (6th Ed.) Chapman & Hall, London.
Alexanderson B. and Borga O (1972) Interindividual differences in plasma protein binding of nortriptylme in man-a twin study. Eur J Clm Pharmacol 4 196–200.
Bass L. and Brackan A. J. (1978) Hepatic elimination of flowing substrates: The distributed model. J Theor. Bzol 72, 161–184.
Bass L. and Wmkler K. (1980) A method of determining intrinsic hepatic clearance from the first-pass effect Clm. Exp. Pharmacol. Physzol 7, 339–343.
Bass L., Keiding S., Winkler K, and Tygstrup H. (1976) Enzymatic elimination of substrates flowing through the intact liver J. Theor. Bzol 61, 393–409
Bertilsson L, Braithwaite R, Tybring G., Garle M., and Borga O (1979) Techniques for plasma protein binding of demethylchlorimipramine. Clin Pharmacol Ther 26, 265–271
Bickel M. H. (1975) Bmding of chlorpromazine and imipramine to red cells, albumin, lipoprotems and other blood components. J Pharm, Pharmacol 27, 733–738.
Boudinot F. D and Jusko W J. (1984) Fluid shifts and other factors affecting plasma protein binding of prednisolone by equilibrium dialysis J. Pharm SCL 73, 774–780.
Borga O., Azarnoff D. L., Forshell G. P., and Sjoqvist F. (1969) Plasma protein binding of tricyclic antidepressants in man. Biochem. Pharmaco1 18, 2135–2143.
Borga O., Azarnoff D. L., and Sloqvist F (1968) Species differences in the plasma protein binding of desrpramine J. Pharm. Pharmacol 20, 571.
Bowers W. F., Fulton S., and Thompson J (1984) Ultrafiltration vs equilibrmm dialysis for determination of free fraction. Clin. Pharmacokinet 9 (suppl l), 48–60
Brodie B. B. (1967) Physicochemical and biochemical aspects of pharmacology. J. Am. Med. Assoc 202, 600–609
Chignell C. F (1981) Molecular Features of Plasma Protem Binding, in Clmzcal Pharmacology m Psychiatry (E. Usdm, ed.) Elsevier, New York.
Curry S. H. (1970a) Plasma protein binding of chlorpromazme. J, Pharm. Pharmacol 22, 193–197
Curry S. H. (1970b) Theroretical changes in drug distribution resulting from changes in binding to plasma proteins and to tissues. J. Pharm. Pharmacol 22, 753–757.
Curry S H. (1972) Relation between binding to plasma protein, apparent volume of distribution, and rate constants of disposition and elimination for chlorpromazine in three species. J Pharm. Pharrnacol 24, 818–819.
Curry S. H. (1980) Drug Disposition and Pharmacokinetrcs (3rd Ed.) Black-well, Oxford.
Curry S. H. (1981) Binding of Psychotropic Drugs to Plasma Protein and its Influence on Drug Distribution, in Clznical Pharmacology in Psychiatry (E. Usdin, ed.) Elsevier, New York.
Curry S. H. (1985) A multiple plate hypothesis of drug elimination. Abstracts: III World Conference on Clinical Pharmacology and Therapeutics, Stockholm (July 27-August 1, 1986). (Suppl.) Actc Pharmacol. Toxtcol
Curry S. H and Hu O Y-P (1984) Evaluation of equihbrmm dialysis volume shifts. A comment. J. Pharmacokmet. Btopharmacol 12, 463–465
Curry S. H. and Whelpton R. (1979) Pharmacokinetics of closely related benzodiazepines Br. J. Clin. Pharmacol 8, 155–215
Curry S. H and Whelpton R. (1983) Manual of Laboratory Pharmacokinetics Wiley, Cichester.
Danon A. and Chen Z. (1979) Binding of imipramine to plasma protems: Effect of hyperlipoprotememia. Clin Pharmacol. Ther 25, 316–321.
Gabay S. and Huang P C. (1984) The Binding Behavior of Phenothiazines and Structurally Related Compounds to Albumin from Several Species, in Phenothiazines and Structurally Related Drugs (I S. Forrest, C J. Carr, and E. Usdin, ed.) Raven, New York.
Gibaldi M. and Perrier D (1982) Pharmacoktnetics (3rd Ed.) Marcel Dekker, New York.
Gillette J. R. (1973) Overview of Protein Binding, in Drug-Protein Binding (A. H. Anton and H M. Solomon, ed.) Ann. NY Acad. Ser 226, 1–362.
Glassman A. H., Hurwic M. J, Kanzler M., Shostak M., and Perel J M. (1970) Imipramme steady-state studies and plasma binding, in Phenothiazines and Structurally Related Drugs (I. S. Forrest, C. J. Carr, E. Usdin, eds.) Raven, New York.
Glassman A. H., Hurwic J. J., and Perel J. M. (1973) Plasma binding of imipramine and cluucal outcome. Am. J. Psychiat 130, 1367–1369
Goldbaum L R. and Smith P. K. (1954) The mteraction of barbiturates with serum albumin and its possible relation to their disposition and pharmacological actions. J Pharmacol Exp. Ther 111, 197–209
Goldstein A (1949) The interactions of drugs and plasma proteins. Pharmucol. Rev 1, 102–16
Goodman L. S. and Gilman A. (1965) The Pharmacologicul Basis of Therupeutics (3rd Ed.) Macmillan, New York.
Hallstrom C., Lader M. H., and Curry S. H. (1979) Dlazepam and N- desmethyldlazepam concentrations in saliva, plasma and CSF. Br. J. Clin Pharmucol 9, 333–339
Hu O Y-P and Curry S. H. (1984), A Simple Approach for Estimation of the Unbound Fraction of Drugs in Equilibrium Dialysis with Consideration of Volume Shift, in Proceedings of 10th Asian Congress of Phurmuceutrcul Scrences, Taipei, Taiwan, R. O. C. 178–183.
Hu O Y-P and Curry S H. (1986) Calculation of fraction bound in equilibrium dialysis with special reference to drug losses by decomposltlon and adsorption Biophurmaceut Drug Dispos 7, 211–214.
Huang J. D. (1983) Errors in estimating the unbound fraction of drugs due to the volume shift in equilibrium dialysis J Phurm. Sci 72, 1368–1369.
Krieglstein J., Melller W., and Staab J. (1972) Hydrophobic and ionic interactions of phenothiazine derivatives with BSA. Bzochem Phurmuco1 21, 985–997.
Levy G. (1980) Effect of plasma protein binding on renal clearance of drugs. J. Phurm. SCL 69, 482–483.
Lima J. J., Macklchan J J, Libertin N., and Sabino J. (1983) Influence of volume shifts on drug binding during equilibrium dialysis. J. Phurmacokin. Blopharm 11, 483–498.
Lockwood G. F. and Wagner J. G. (1983) Plasma volume changes as the result of equihbrlum dialysis. J. Phurm. Phurmucol 35, 387–388.
Meyer M. C. and Guttman D. E. (1968) The binding of drugs by plasma proteins. J. Phurmucol. Sci 57, 895–918.
Mueller V. W. and Potter J M (1981). Binding of cortisol to human albumin and serum: The effect of protein concentration. Biochem. Phurmucol 30, 727–733.
Nyberg G., Axelsson R., and Martensson E. (1978) Binding of thioridazine and thioridazine metabolites to serum proteins in psychiatric patients. Eur. J. Clm. Phurmucol 14, 341–350
Pang S. and Rowland M. (1977) Hepatic clearance of drugs. Theoretical conslderatlons of a “well-stirred” model and a “parallel-tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity in hepatic drug clearance. J, Phurmucokm. Blopharm 5, 625–653
Piafsky K. M. and Borga O. (1977) Plasma protein binding of basic drugs. II. Importance of α(in1-acid glycoprotein for interindividual variation. Clin. Pharmacol. Ther 22, 545–549.
Piafsky K. M., Borga O., Odar-Cederlof I., Johannsson C., and Sjoqvist F. (1978) Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma α1-acid glycoprotein. N Eng J. Med 299, 1435–1439.
Potter W. Z., Muscettola G., and Goodwin F. K. (1979) Binding of imipramine to plasma protein and to brain tissue. Relationship to CSF tricychc levels in man. Psychopharmacology 63, 187–192.
Rowland M., Benet L. Z, and Graham G. G. (1973) Clearance concepts in pharmacokinetics. J. Pharmacokin Biopharm 1, 123–136.
Tozer T. N., Gambertoglio J. G., Furst D. E., Avery D. S, and Holford N. H. G. (1983) Volume shift and protein bmdmg estimates using equilibrium dialysis: Application to prednisolone binding in humans. J. Phnrm. Scz 72, 1441–1446
Vallner J. (1974) Binding of drugs by albumin and plasma protein. J Pharm. Scz 66, 447–465
Veldstra H. (1956) Synergism and potenhation. Pharmacol. Rev 8, 339–387
Wagner J. G. (1985) Commentary: Relationships among the venous equilibration (“well-stirred”) model, the sinusoidal perfusion (“parallel-tube”) model, and a specific two-compartment open model. Drug Metab. Dlspos 13, 119–120.
Wagner J. G., Szpuner G. J., and Ferry J. J. (1984) Commentary: Exact mathematical equivalence of the venous equilibration (“wellstirred”) model, the smusoidal perfusion (“parallel-tube”) model, and a specific two-compartment open model. Drug Metab. Dlspos 12, 385–388.
Whelpton R. (1978) Lipophilicity as a factor in the biochemical pharmacology of tranquillizing drugs. PhD thesis, University of London, London, UK.
Wilkinson G. R. and Shand D. G. (1975) A physiological approach to hepatic drug clearance. Clin. Pharmacol. Ther 18, 377–390.
Winkler K., Keiding S., and Tygstrup H. (1973) Clearance as a Quantitative Measure of Liver Function, in The Liver, Quantitative Aspects of Structure and Functron (G. Paumgartner and R Preisig, eds.) Kaiger, Basel.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 The Humana Press Inc.
About this protocol
Cite this protocol
Curry, S.H., Hu, O.YP., Whelpton, R. (1988). Protein Binding of Psychotropic Drugs. In: Boulton, A.A., Baker, G.B., Coutts, R.T. (eds) Analysis of Psychiatric Drugs. Neuromethods, vol 10. Humana Press. https://doi.org/10.1385/0-89603-121-7:1
Download citation
DOI: https://doi.org/10.1385/0-89603-121-7:1
Publisher Name: Humana Press
Print ISBN: 978-0-89603-121-0
Online ISBN: 978-1-59259-615-7
eBook Packages: Springer Protocols